<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02495961</url>
  </required_header>
  <id_info>
    <org_study_id>2014-01</org_study_id>
    <nct_id>NCT02495961</nct_id>
  </id_info>
  <brief_title>Study of Chronic Degenerative Diseases</brief_title>
  <official_title>Study of Chronic Degenerative Diseases, Translational Medicine Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asociación Científica Latina A.C.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad Autonoma del Estado de Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ciprés Grupo Médico CGM SC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asociación Científica Latina A.C.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of obesity and type 2 diabetes mellitus (DM) in children have been increasing&#xD;
      in parallel at an alarming rate. In particular, the increasing prevalence of type 2 DM is&#xD;
      attributable to genetic factors, clinical (waist circumference, adiposity and physical&#xD;
      condition) and biochemical (insulin secretion and sensitivity, lipids and inflammation) risk,&#xD;
      each of which represents an independent risk.&#xD;
&#xD;
      As has already studied and published in the investigators' group, the child population of&#xD;
      Toluca has greater expression of cardiovascular risk factors than their counterparts in&#xD;
      Bogota, Colombia. The metabolic characterization of the young population of Toluca and Bogota&#xD;
      with new biomarkers such as homocysteine and leptin is an activity that aims to provide more&#xD;
      metabolic data affecting young people.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      After six months of follow-up there will be a greater relative risk in Mexican population to&#xD;
      have identified another component of metabolic syndrome compared to the young population of&#xD;
      Colombia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective:&#xD;
&#xD;
      To compare the expression levels of cardiovascular risk markers in young people between 5 and&#xD;
      12 years of Toluca, Mexico and Bogota, Colombia.&#xD;
&#xD;
      Material and methods:&#xD;
&#xD;
      Type of study: prospective, descriptive, comparative, and longitudinal.&#xD;
&#xD;
      Sample Calculation:&#xD;
&#xD;
      For a cohort study and taking into account that in the investigators' previous publication in&#xD;
      the Colombian population only 13% (sick rate in unexposed group) had an altered metabolic&#xD;
      parameter; accepting an alpha risk of 0.05 and a beta of 0.2 on a risk bilateral contrast, 57&#xD;
      subjects were required in the exposed group (Mexican population) and 57 in unexposed to&#xD;
      detect a minimum relative risk of 3 to find other alteration to metabolic syndrome after six&#xD;
      months follow-up.&#xD;
&#xD;
      Measurements:&#xD;
&#xD;
      The International Physical Activity Questionnaire (IPAQ) will be applied to all children.&#xD;
      Dietary history of three days and physical examination (height in cm , weight in kg and waist&#xD;
      circumference in centimeters) and blood pressure (mmHg) data will be recorded. Blood samples&#xD;
      will be taken to analyze glucose, cholesterol, HDL, triglycerides, homocysteine and leptin.&#xD;
&#xD;
      Statistics:&#xD;
&#xD;
      Variables will be tested for normality through the Kolmogorov-Smirnov and Shapiro-Wilk&#xD;
      formulas. Variables related to the physiological and metabolic functions and anthropometric&#xD;
      measurements will be reported in mean and standard deviation. The differences in the&#xD;
      laboratorial and anthropometrical variables will be analyzed with the Student t test. A&#xD;
      difference will be considered significant with a p value ≤ 0.05. The statistical program used&#xD;
      is the Statistical Package for the Social Sciences (SPSS) version 19.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Metabolic syndrome component detection</measure>
    <time_frame>six months</time_frame>
    <description>After six months of a basal evaluation, children will be re-examined in each component of the metabolic syndrome.&#xD;
Metabolic syndrome component detection will be determined by the measure of glucose (mg/dl), cholesterol (mg/dl), triglycerides (mg/dl), high-density lipoproteins (HDL), waist circumference (cm), hip circumference (cm) and blood pressure (mmHg).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">57</enrollment>
  <condition>Metabolic Syndrome X</condition>
  <arm_group>
    <arm_group_label>Low risk population</arm_group_label>
    <description>Colombian children, between 6 and 12 years old, regular students of a Primary school.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High risk population</arm_group_label>
    <description>Mexican children, between 6 and 12 years old, regular students of a Primary school.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary school students.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary school students of medium-low income.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children with disabilities or a known chronic disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugo Mendieta Zerón, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asociación Científica Latina A.C.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asociación Científica Latina A.C.</name>
      <address>
        <city>Toluca</city>
        <state>State of Mexico</state>
        <zip>50120</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>July 9, 2015</study_first_submitted>
  <study_first_submitted_qc>July 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2015</study_first_posted>
  <last_update_submitted>February 15, 2016</last_update_submitted>
  <last_update_submitted_qc>February 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hyperlipidemias</keyword>
  <keyword>hyperglycemia</keyword>
  <keyword>hypertension</keyword>
  <keyword>leptin</keyword>
  <keyword>hyperhomocysteinemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

